Skip to content

Clinical study on the short-term and long-term efficacy and safety of esophageal hiatal hernia with complete left-side surgical approach and traditional surgical approach

Clinical study on the short-term and long-term efficacy and safety of esophageal hiatal hernia with complete left-side surgical approach and traditional surgical approach

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000034028
Enrollment
Unknown
Registered
2020-06-21
Start date
2021-01-01
Completion date
Unknown
Last updated
2020-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hiatal hernia

Interventions

Experimental Group:Complete left surgical approach
Control Group:Traditional Surgical approach

Sponsors

Beijing Friendship Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Through gastroscopy and high-resolution esophageal manometry, 24-hour esophageal pH test, upper gastrointestinal angiography, and abdominal CT examination support esophageal hiatal hernia (type II\III\IV) with GERD; 2. The patient has reflux symptoms such as reflux, acid reflux, and burning pain in the chest area, and the symptoms have not improved significantly after regular medical conservative treatment; 3. Surgical treatment, normal liver, kidney and bone marrow function; 4. Ability to abide by the plan during the study and sign an informed consent; 5. The patient is willing to follow up and cooperate with the full-time staff to make relevant records;

Exclusion criteria

Exclusion criteria: 1. Patients with severe cardiopulmonary disease and intolerance to surgery; 2. With history of gastrointestinal surgery, malignant tumor history, history of chemotherapy or radiotherapy. 3. Uncontrollable medical diseases (including unstable angina pectoris, myocardial infarction, cerebrovascular accident within 6 months); 4. Cannot receive general anesthesia or surgical treatment due to other organs in the whole body; 5. Have a history of uncontrolled epilepsy, central nervous system diseases or mental disorders; 6. Those who need immunosuppressive treatment for organ transplantation; 7. Severe uncontrolled repeated infections, or other serious uncontrolled concomitant diseases; 8. Continuous systemic steroid hormone treatment; 9. Pregnant or breastfeeding women of childbearing age; 10. Participate in other clinical trials at the same time.

Design outcomes

Primary

MeasureTime frame
GLQI life quality score;

Secondary

MeasureTime frame
Incidence of gallstone;Incidence of gastric emptying disorders;

Countries

China

Contacts

Public ContactYin jie

Beijing Friendship Hospital

yj232325@sina.com+86 15011302788

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 21, 2026